Valuation: Sandoz Group AG

Capitalization 18.4B 17.53B 16.44B 14.58B 26.2B 1,561B 28.95B 202B 74.75B 643B 69.14B 67.59B 2,828B P/E ratio 2024 *
28x
P/E ratio 2025 * 19.1x
Enterprise value 21.82B 20.79B 19.5B 17.29B 31.07B 1,851B 34.34B 240B 88.66B 763B 82B 80.17B 3,354B EV / Sales 2024 *
2.09x
EV / Sales 2025 * 1.95x
Free-Float
-
Yield 2024 *
1.48%
Yield 2025 * 1.93%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.36%
1 week-3.36%
Current month-7.65%
1 month-8.11%
3 months+5.25%
6 months+15.20%
Current year+36.99%
More quotes
1 week
37.06
Extreme 37.06
38.71
1 month
37.06
Extreme 37.06
40.93
Current year
25.33
Extreme 25.33
41.16
1 year
25.33
Extreme 25.33
41.16
3 years
22.70
Extreme 22.7
41.16
5 years
22.70
Extreme 22.7
41.16
10 years
22.70
Extreme 22.7
41.16
More quotes
Director TitleAgeSince
Chief Executive Officer 57 2022-01-16
Director of Finance/CFO 56 2024-06-30
Chief Tech/Sci/R&D Officer - -
Manager TitleAgeSince
Director/Board Member 61 2023-07-31
Chairman 64 2023-02-28
Director/Board Member 59 2023-07-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.51%-3.36%+32.77% - 18.4B
+0.44%0.00%+48.89%+138.19%51.04B
-1.79%-4.09%+52.41%+112.24%31.31B
+0.13%-3.40%+20.74%+61.91%13.75B
+0.20%+0.05%+54.00%+109.30%11.58B
-.--%+0.14% - - 6.79B
-.--%-1.95% - - 5.73B
-1.87%-4.52%-35.47%-38.81%5.29B
-0.61%+1.46%+3.88%+19.87%5.24B
-1.10%-1.72%+90.40%+188.73%5.1B
Average -0.50%-1.39%+33.45%+84.49% 15.42B
Weighted average by Cap. -0.36%-1.37%+41.94%+109.85%
See all sector performances

Financials

2024 *2025 *
Net sales 10.43B 9.94B 9.32B 8.26B 14.85B 885B 16.42B 115B 42.38B 365B 39.2B 38.32B 1,603B 11.12B 10.59B 9.93B 8.81B 15.83B 943B 17.5B 122B 45.17B 389B 41.78B 40.84B 1,708B
Net income 629M 599M 562M 498M 895M 53.35B 990M 6.91B 2.56B 21.98B 2.36B 2.31B 96.65B 947M 903M 846M 751M 1.35B 80.37B 1.49B 10.41B 3.85B 33.11B 3.56B 3.48B 146B
Net Debt 3.42B 3.26B 3.06B 2.71B 4.87B 290B 5.39B 37.61B 13.91B 120B 12.86B 12.58B 526B 3.23B 3.08B 2.89B 2.56B 4.6B 274B 5.09B 35.51B 13.13B 113B 12.15B 11.88B 497B
More financial data * Estimated data
Logo Sandoz Group AG
Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.
Employees
22,633
More about the company
Date Price Change Volume
24-12-13 37.07 CHF -0.51% 500,413
24-12-12 37.26 CHF -0.59% 634,648
24-12-11 37.48 CHF -1.00% 659,059
24-12-10 37.86 CHF -0.18% 617,151
24-12-09 37.93 CHF -1.12% 797,925

Delayed Quote Swiss Exchange, December 13, 2024 at 11:31 am EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
surperformance-ratings-light-chart SANDOZ-GROUP-AGMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
41.94USD
Average target price
47.55USD
Spread / Average Target
+13.37%
Consensus

Quarterly revenue - Rate of surprise